Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons

Journal of the National Cancer Institute

Volumn 92, Issue 10, 2000, Pages 803-811

  Smith, Leslie E ^a   Denissenko, Mikhail F ^a,d   Bennett, William P ^a   Li, Haiying ^b   Amin, Shantu ^c   Tang, Moon Shong ^b,e   Pfeifer, Gerd P ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

^d BD Technologies   (United States)

^e NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; BENZO[C]PHENANTHRIDINE DERIVATIVE; CHRYSENE DERIVATIVE; CIGARETTE SMOKE; ORGANIC MATTER; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P53;

ARTICLE; CODON; COMBUSTION; CONTROLLED STUDY; DNA DAMAGE; GENE MUTATION; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; LUNG CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034679057     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.10.803     Document Type: Article

References (59)

1. Harris CC. p53 tumor suppressor gene: from the basic research laboratory to the clinic - an abridged historical perspective. Carcinogenesis 1996;17: 1187-98.
2. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
3. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Sheilds PG, Harris CC. Molecular epidemiology of human cancer risk: gene - environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 1999; 187:8-18.
4. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87: 175-82.
5. Hecht SS, Carmella SG, Murphy SE, Foiles PG, Chung FL. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer. J Cell Biochem Suppl 1993;17F:27-35.
6. Harvey RG. Polycyclic aromatic hydrocarbons: chemistry and carcinogenicity. Cambridge (U.K.): Cambridge University Press; 1991.
7. Wynder EL, Hoffmann D. A study of tobacco carcinogenesis. VII. The role of higher polycyclic hydrocarbons. Cancer 1959;12:1079-86.
8. Van Duuren BL. The polynuclear aromatic hydrocarbons in cigarette smoke condensate II. J Natl Cancer Inst 1958;21:623-30.
9. Cavalieri EL, Rogan EG. Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 1995;25: 677-88.
10. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996;274:430-2.
11. Tornaletti S, Pfeifer GP. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers. Oncogene 1995;10:1493-9.
12. Rideout WM 3d, Coetzee GA, Olumi AF, Jones PA. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990;249:1288-90.
13. Denissenko MF, Chen JX, Tang MS, Pfeifer GP. Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci U S A 1997;94:3893-8.
14. Chen JX , Zeng Y, West M, Tang MS. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res 1998;58: 2070-5.
15. Denissenko MF, Pao A, Pfeifer GP, Tang M. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene 1998; 16:1241-7.
16. Eisenstadt E, Warren AJ, Porter J, Atkins D, Miller JH. Carcinogenic epoxides of benzo[a]pyrene and cyclopenta[cd]pyrene induce base substitutions via specific transversions. Proc Natl Acad Sci U S A 1982;79: 1945-9.
17. Mazur M, Glickman B. Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells. Somat Cell Mol Genet 1988;14:393-400.
18. Yang JL, Maher VM, McCormick JJ. Kinds of mutations formed when a shuttle vector containing adducts of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene replicates in human cells. Proc Natl Acad Sci U S A 1987;84: 3787-91.
19. Chen RH, Maher VM, McCormick JJ. Effect of excision repair by diploid human fibroblasts on the kinds and locations of mutations induced by (+/-)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene in the coding region of the HPRT gene. Proc Natl Acad Sci U S A 1990; 87:8680-4.
20. Jelinsky SA, Liu T, Geacintov NE, Loechler EL. The major N2-Gua adduct of (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing G→A and G→C, in addition to G→T mutations. Biochemistry 1995;34: 13545-53.
21. Coulondre C, Miller JH, Farabaugh PJ, Gilbert W. Molecular basis of base substitution hotspots in Escherichia coli. Nature 1978;274:775-80.
22. Jones PA. DNA methylation errors and cancer. Cancer Res 1996;56: 2463-7.
23. Hernandez-Boussard T, Hainaut P. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database [published erratum appears in Environ Health Perspect 1998;106: A421]. Environ Health Perspect 1998;106:385-91.
24. International Agency on the Research of Cancer (IARC). Polynuclear aromatic compounds, part 1, chemical, environmental, and experimental data. IARC Monogr Eval Carcinog Risk Chem Hum, vol 32. Lyon (France): IARC; 1983. p. 37-8.
25. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1995;50:307-64.
26. Hecht SS, Bondinell WE, Hoffmann D. Chrysene and 5-methylchrysenes: presence in tobacco smoke and carcinogenicity. J Natl Cancer Inst 1974; 53:1121-33.
27. McKay JF, Lathham DR. Polyaromatic hydrocarbons in high boiling petroleum distillates: isolation by gel permeation chromatography and identification by fluorescence spectrometry. Anal Chem 1973;45:1050-5.
28. Glatt H, Wameling C, Elsberg S, Thomas H, Marquardt H, Hewer A, et al. Genotoxicity characteristics of reverse diol-epoxides of chrysene. Carcinogenesis 1993;14:11-9.
29. Buening MK, Levin W, Karle JM, Yagi H, Jerina DM, Conney AH. Tumorigenicity of bay-region epoxides and other derivatives of chrysene and phenanthrene in newborn mice. Cancer Res 1979;39:5063-8.
30. Amin S, Huie K, Melikian AA, Leszczynska JM, Hecht SS. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene. Cancer Res 1985; 45:6406-12.
31. Hecht SS, Amin S, Huie K, Melikian AA, Harvey RG. Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis. Cancer Res 1987;47: 5310-5.
32. Melikian AA, Prahalad KA, Amin S, Hecht SS. Comparative DNA binding of polynuclear aromatic hydrocarbons and their dihydrodiol and bay region diolepoxide metabolites in newborn mouse lung and liver. Carcinogenesis 1991;12:1665-70.
33. You L, Wang D, Galati AJ, Ross JA, Mass MJ, Nelson GB, et al. Tumor multiplicity, DNA adducts and K-ras mutation patterns of 5-methylchrysene in strain A/J mouse lung. Carcinogenesis 1994;15:2613-8.
34. Glatt H, Piee A, Pauly K, Steinbrecher T, Schrode R, Oesch F, et al. Fjordand bay-region diol-epoxides investigated for stability. SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells. Cancer Res 1991;51:1659-67.
35. Levin W, Wood AW, Chang RL, Ittah Y, Croisy-Delcey M, Yagi H, et al. Exceptionally high tumor-initiating activity of benzo(c)phenanthrene bay-region diol-epoxides on mouse skin. Cancer Res 1980;40:3910-4.
36. Dipple A, Pigott MA, Agarwal SK, Yagi H, Sayer JM, Jerina DM. Optically active benzo[c]phenanthrene diol epoxides binding extensively to adenine in DNA. Nature 1987;327:535-6.
37. Amin S, Krzeminski J, Rivenson A, Kurtzke C, Hecht SS, el-Bayoumy K. Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. Carcinogenesis 1995;16:1971-4.
38. Giles AS, Seidel A, Phillips DH. Covalent DNA adducts formed in mouse epidermis by benzo[g]chrysene. Carcinogenesis 1996;17:1331-6.
39. Amin S, Desai D, Dai W, Harvey RG, Hecht SS. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene. Carcinogenesis 1995;16: 2813-7.
40. Yuan W, Kiselyov AS, Harvey RG, Carothers AM. Mutagenic specificity of syn-benzo[g]chrysene 11,12-dihydrodiol 13,14-epoxide in the dihydrofolate reductase gene of Chinese hamster ovary cells. Carcinogenesis 1995; 16:2869-73.
41. 32P-postlabeling. Chem Res Toxicol 1995;8:591-9.
42. Pataki J, Lee H, Harvey RG. Carcinogenic metabolites of 5-methylchrysene. Carcinogenesis 1983;4:399-402.
43. Amin S, Huie K, Hecht SS, Harvey RG. Synthesis of 6-methylchrysene-1,2-diol-3,4-epoxides and comparison of their mutagenicity to 5-methylchrysene-1,2-diol-3,4-epoxides. Carcinogenesis 1986;7:2067-70.
44. Kiselyou AA, Lee HM, Harvey RG. Efficient syntheses of the anti-diol and syn-diol epoxide metabolites of the carcinogenic polycyclic aromatic hydrocarbon benzo[g]chrysene. J Org Chem 1995;60:6123-8.
45. Krzeminski J, Lin JM, Amin S, Hecht SS. Synthesis of Fjord region diol epoxides as potential ultimate carcinogens of dibenzo[a,l]pyrene. Chem Res Toxicol 1994;7:125-9.
46. Misra B, Amin S. An improved synthesis of anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide via 4-methoxybenzo[c]phenanthrene. J Org Chem 1990;55:4478-80.
47. Tang M-s. Mapping and quantification of bulky chemical-induced DNA damage using UvrABC nucleases. In: Pfeifer GP, editor. Technologies for detection of DNA damage and mutations. New York (NY): Plenum Press; 1996. p. 139-53.
48. Tang M-s, Zheng JB, Denissenko MF, Pfeifer GP, Zheng Y. Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene. Carcinogenesis 1999;20:1085-9.
49. Tornaletti S, Rozek D, Pfeifer GP. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer [published erratum appears in Oncogene 1993;8:3469]. Oncogene 1993;8: 2051-7.
50. Tornaletti S, Pfeifer GP. Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. Science 1994;263:1436-8.
51. Tornaletti S, Pfeifer GP. Ligation-mediated PCR for analysis of UV damage. In: Pfeifer GP, editor. Technologies for detection of DNA damage and mutations. New York (NY): Plenum Press; 1996. p. 199-209.
52. DeMarini DM, Shelton ML, Bell DA. Mutation spectra in Salmonella of complex mixtures: comparison of urban air to benzo[a]pyrene. Environ Mol Mutagen 1994;24:262-75.
53. DeMarini DM, Shelton ML, Levine JG. Mutation spectrum of cigarette smoke condensate in Salmonella: comparison to mutations in smoking-associated tumors. Carcinogenesis 1995;16:2535-42.
54. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, et al. IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 1998;26:205-13.
55. Denissenko MF, Koudriakova TB, Smith L, O'Connor TR, Riggs AD, Pfeifer GP. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene 1998;17:3007-14.
56. Wei SJ, Chang RL, Cui XX, Merkler KA, Wong CQ, Yagi H, et al. Dose-dependent differences in the mutational profiles of (-)-(1R,2S,3S,4R)-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene and its less carcinogenic enantiomer. Cancer Res 1996;56: 3695-703.
57. Bigger CA, St John J, Yagi H, Jerina DM, Dipple A. Mutagenic specificities of four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides. Proc Natl Acad Sci U S A 1992;89:368-72.
58. Routledge MN, Wink DA, Keefer LK, Dipple A. Mutations induced by saturated aqueous nitric oxide in the pSP189 supF gene in human Ad293 and E. coli MBM7070 cells. Carcinogenesis 1993;14:1251-4.
59. Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, et al. Distribution of p53 and K-ras mutations in human lung cancer tissues. Carcinogenesis 1997;18:473-8.